Because femininity is timeless.
A new and innovative technique combines the action of the infrared laser and the Ladylift® handpiece in order to accelerate the production and the remodeling of mucosa collagen.
LASER TREATMENT LADYLIFT®

Age and muscular stress often cause an atrophic process within the vagina. If not adequately treated, this likely results in dryness, sexual difficulties, itching, burning, tissue laxity and urinary incontinence. 

The main cause of this is the loss of tone of the vaginal mucosa. 

The Ladylift® treatment targets the vaginal mucosa. The wavelength (1470nm), combined with the controlled, radial emission of the Ladylift® handpiece, has a bio-modulating effect that stimulates neocollagenesis and regenerates the epithelium and the connective tissue. This action rejuvenates the mucosa by restoring firmness, flexibility and hydration; therefore, considerably reducing symptoms that are usually attributes to menopause. Ladylift®also has a positive effect on urinary incontinence, in many cases restoring the normal functionality. 

The main advantage of using a diode laser is that the laser can penetrate deeper, targeting the mucosa, without causing an ablative thermal injury. 

The handpiece design and circular emission are unique to the Ladylift®. They allow for a painless treatment. The combination also ensures that the laser evenly targets all tissue on the inner walls of the vagina. 

Suggested settings are presented within the software for ease-of-use, but the physician can manually alter the settings. Additional handpieces are available for internal and external vulvar treatments, as well as aesthetic microsurgery.

 

What are the results of Ladylift® in the treatment of GSM?

                       

                         Changes in the Female Sexual Function Index at baseline and after Ladylift® treatment                                   

 

 

        Changes in the atrophy index before and after Ladylift® treatment
         

 

                Changes in the GSM and stress urinary incontinence before and after Ladylift® treatment

                    

 

As it has been reported in the first scientific paper that contains the results of a study that has been conducted on a homogeneous sample of 100 women (Open Journal of Obstetrics and Gynecology, 201,8, 113 -121, D.Dodero, F.Murina at Al.) the Ladylift® laser procedure gives satisfactory results since the very first session. The process of biostimulation and rejuvenation requires a few weeks in order to be completed therefore the results can be fully appreciated after 2 months since the end of the tratment.


 

                  

If you are interested in receiveing the scientific reports about our Ladylift® treatment

write to [email protected]

 

 

 

 

 

 

 

 

Applications

  • GSM - Genitourinary syndrome of menopause
  • Vaginal atrophy
  • Vaginal laxity
  • Diseases associated to postpartum alteration
  • Vaginal rejuvenation
  • HPV
  • Cysts
  • Treatment of scars
  • Dryness
  • Itching

Advantages

  • Fully outpatient process without anesthesia
  • No side effects
  • Effective and painless
  • Non-invasive
Ladylift® Vaginal Handpiece
Gynaecological Surgical Probe
Vulvo-perineal Handpiece
Contacts
Testimonials

As the Head Physician of a Gynaecology Department, I first started using gynecology lasers 6 years ago, diving into a cultural and methodological revolution. After using two ERBIUM lasers, I opted for LADYLIFT® first solid state laser and its excellent regenerative capacity. The pilot clinical study led us to extraordinary results, such as the almost complete resolution of urge incontinence (95%). As the Head of the Urogynecology Department of the San Giuseppe Hospital in Milan, I have reconsidered performing vaginal rehabilitation using the non-ablative Ladylift® laser at the early stages of the clinical care pathway to treat urinary and pelvic floor incontinence in women over 50.

Danilo Dodero, Gynaecologist, Genova

Ladylift® non-ablative diode laser has proven to be a powerful weapon against the genitourinary syndrome in women going through menopause. In my personal experience, I have seen several women restoring the normal hydration of the vulvovaginal mucus, also recovering from urge incontinence up to the almost total resolution of the problem in light incontinence.
Given it is a non-ablative laser, it does not leave any abrasions, burns or injuries. Also, the treatment is well tolerated by the patient. In older patients and in those with persistent atrophy, the patient had to undergo a hormonal local therapy first so as to increase the basal hydration of tissues, which was later boosted by the laser.
In young patients or women who had entered menopause very recently, the results were excellent, especially in patients with forced menopause due to a cancer. The outcomes can be seen after the very first session and three sessions every two weeks are usually enough to complete the treatment. Futhermore, the Ladylift® laser is handy and easy to use, it can be carried around pretty much everywhere. As a result, it allows meeting the needs of patients living in a city or in remote areas.

Michela Angelucci, Gynaecologist, Roma

I have been using the Ladylift® laser for external and internal vulvovaginal treatments. The outcomes are excellent and the patient tolerability is also very good. The laser is very easy to use. I strongly recommend it.

Elisanna Sabatini, Gynaecologist, Pescara

Supported by a colleague of mine who is a gynaecologist, I have recently started using the Ladylift® laser in patients under SERMs (tamoxiphen) suffering from recurrent cystitis, dryness, burning sensation and dyspareunia. There has been a good resolution of symptoms at the end of the treatment sessions.

Monica Baldessin, Aesthetic Doctor, Treviso
THANK YOU

We have received your request, we will contact you shortly.

ERROR

There was a problem, please try again.

Disclosures
Some of the information contained in this website are exclusively directed to healthcare professionals, in compliance with art. 21 of the Decree n. 46 of February 24th, 1997 and subsequent modifications and integrations, and the Guidelines of the Italian Ministry of Health of March 28th, 2013. The possibility to continue browsing and access to the content relating to products, technical descriptions and commercial offers is subject to the statement made by the user, under his own responsibility, to be a healthcare professional. The simple visitors will be redirected to institutional page of Eufoton.
Cookie Policy

This website uses cookies. By continuing to browse this site, you are agreeing to our use of cookies. Find out more by clicking here. ACCEPT or DISABLE.

By pressing Continue I declare under my own responsibility to be a healthcare provider and continuing to browse I declare to accept the cookie information.

I am a health worker
Continue arrow_forward
I am a visitor
Home arrow_forward